text.skipToContent text.skipToNavigation

Sartorius Stedim Biotech Investor Relations

Preliminary Full-Year 2016 Results

Dr. Joachim Kreuzburg, CEO, discussed the company's results with analysts and investors on Monday, January 30, 2017, in a teleconference. To listen to the recording please click here.

Nine-Month 2016 Figures

Full-Year 2015 Results

Facts & Figures

Download a brief overview of Sartorius Stedim Biotech and its current economic development.

Sartorius Stedim Biotech Share (DIM)